Summary

Respiratory diseases are major causes of disease burden and mortality throughout the world. In Germany, alongside acute respiratory infections (ARI), chronic lung diseases – including lung cancer, chronic obstructive pulmonary disease (COPD), and asthma – are of particular socioeconomic importance. ARI incidence rates differ significantly according to age, season and year. They are recorded as weekly consultation rates as reported by selected outpatient and inpatient care facilities. The respiratory care devices market in Germany is a significant and dynamic sector within the broader medical device industry. In 2022, Germany's public health agency reported more than 7 million cases of respiratory illnesses in a month. Babies and children have been infected by a virus that could threaten lives. Germany has established itself as a global leader in the manufacturing of respiratory care devices, underlining the country's commitment to producing high-quality, cutting-edge medical equipment. One of the primary reasons for Germany's success in this sector is its strong focus on research and development. Leading German companies invest heavily in R&D, which enables them to innovate and introduce advanced technologies that improve patient outcomes continuously. This commitment to innovation also extends to environmentally sustainable practices, with an emphasis on energy efficiency and reducing the environmental footprint of respiratory care devices. Additionally, Germany boasts a highly skilled and well-educated workforce in the field of medical technology. The country's universities and research institutions collaborate closely with industry leaders to provide a steady stream of talent and expertise to drive further advancements in respiratory care technology. Furthermore, Germany's adherence to strict quality assurance standards, such as ISO certifications and CE marking, ensures that products manufactured in the country are in line with international regulatory requirements and are safe for use in a global market. Germany's strategic location within Europe further enhances its role in the respiratory care device manufacturing industry. It serves as a key distribution hub, allowing companies to efficiently supply their products to both domestic and international markets. This positioning, coupled with the country's robust transportation and logistics infrastructure, contributes to the industry's competitiveness and global reach.

According to the research report "Germany Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the Germany Construction Chemicals market was valued more than USD 1 Billion in 2022. The respiratory care devices market in Germany is experiencing significant expansion, reflecting the growing importance of respiratory health and the continuous advancements in medical technology. As the aging population in Germany continues to grow, so does the prevalence of these respiratory ailments, creating a sustained need for innovative solutions to manage and treat these conditions. The COVID-19 pandemic has underscored the critical role of respiratory care devices, particularly ventilators and oxygen therapy equipment, in supporting patients with severe respiratory distress. This heightened awareness of the importance of such devices in emergency situations has led to investments in healthcare infrastructure and stockpiling to ensure preparedness for future crises. Germany's reputation for quality and precision in manufacturing has positioned it as a preferred destination for both domestic and international consumers seeking reliable and high-performance respiratory care devices. German manufacturers have continued to invest in research and development, resulting in the introduction of state-of-the-art devices with enhanced features, greater patient comfort, and improved therapeutic outcomes. The German government's commitment to healthcare and the presence of a robust regulatory framework ensure that respiratory care devices are produced in compliance with the highest safety and quality standards. This regulatory certainty and adherence to international standards have further bolstered the country's position as a trusted supplier in the global market.

Based on product type market is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. Among them market is majorly dominated by therapeutic devices with a significant market share. Meanwhile, diagnostic devices, including advanced imaging technologies and pulmonary function tests, facilitate accurate and timely diagnosis, a critical step in ensuring appropriate treatment. The market's diverse and dynamic nature is further enriched by the consumables and accessories category, which encompasses items like masks, filters, and tubing necessary for the functioning of respiratory equipment. According to the disease indication, the report consists of chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other respiratory conditions. COPD emerges as the front-runner, significantly dominating the market due to its high prevalence and the substantial demand for advanced respiratory equipment for its management. This chronic and progressive lung disease necessitates a wide array of therapeutic, monitoring, and diagnostic devices, which contributes significantly to the market's overall revenue. The market is significantly impacted by asthma, a common respiratory condition for which nebulizers and inhalers are essential tools in asthma treatment. The need for diagnostic and monitoring equipment has increased due to infectious diseases, especially when it comes to respiratory infections like COVID-19, highlighting their substantial market share. Additionally, a variety of respiratory conditions are included in the "other disease indications" category, which adds to the market's resilience overall.

Hospitals are now the main player in many markets when it comes to end users of respiratory equipment. Their extensive infrastructure, specific medical knowledge, and quick access to a large variety of breathing devices make them essential participants. There has been a notable shift with the introduction of home care settings. In the near future, home care settings will play an increasingly important role in the industry, marking a substantial shift in its trajectory. Numerous causes, including the evolution of healthcare practices that prioritize patient-centred and personalized treatment, support this transition. Advances in technology have facilitated the development of user-friendly and portable respiratory devices, making it increasingly viable to offer effective medical treatment within the comforts of one's home. The rising prevalence of chronic respiratory conditions, such as COPD and sleep apnea, has driven the need for efficient home care solutions, thus promoting the concept of home settings taking a more substantial role in the respiratory equipment market. This trend aims not only to enhance patient comfort and satisfaction but also to reduce the burden on hospital resources, lower healthcare costs, and offer more convenient and personalized care options for individuals with respiratory ailments.

Considered in this report:
• Geography: Germany
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Germany Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents